share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股sec公告 ·  05/20 16:51
Moomoo AI 已提取核心信息
On May 14, 2024, Applied UV, Inc., a company listed on The Nasdaq Stock Market LLC under the trading symbols AUVI for its common stock and AUVIP for its 10.5% Series A Cumulative Perpetual Preferred Stock, reported a significant change in its financial oversight. The company announced that Mazars USA LLP, its independent registered public accounting firm, officially resigned. This resignation was anticipated following an advisory notice from Mazars on April 17, 2024, stating their intention to resign effective with the filing of Applied UV's Quarterly Report for the period ended March 31, 2024, and no later than May 31, 2024. The audit reports for the fiscal years ended December 31, 2023, and December 31, 2022, by Mazars did not contain any adverse opinion or disclaimer and were not qualified or modified...Show More
On May 14, 2024, Applied UV, Inc., a company listed on The Nasdaq Stock Market LLC under the trading symbols AUVI for its common stock and AUVIP for its 10.5% Series A Cumulative Perpetual Preferred Stock, reported a significant change in its financial oversight. The company announced that Mazars USA LLP, its independent registered public accounting firm, officially resigned. This resignation was anticipated following an advisory notice from Mazars on April 17, 2024, stating their intention to resign effective with the filing of Applied UV's Quarterly Report for the period ended March 31, 2024, and no later than May 31, 2024. The audit reports for the fiscal years ended December 31, 2023, and December 31, 2022, by Mazars did not contain any adverse opinion or disclaimer and were not qualified or modified, except for an explanatory paragraph regarding the company's ability to continue as a going concern. There were no disagreements on accounting principles or practices, financial statement disclosure, or auditing scope or procedure between the company and Mazars during the fiscal years mentioned and up to the resignation date. Furthermore, there were no reportable events as defined in Item 304(a)(1)(v) of Regulation S-K. Applied UV has received a letter from Mazars, dated May 20, 2024, agreeing with the statements made in the disclosure, which is attached as Exhibit 16.1 to the report filed with the SEC. The report was signed by Mike Riccio, Chief Financial Officer of Applied UV, Inc.
2024年5月14日,在纳斯达克股票市场有限责任公司上市的公司,其普通股的交易代码为AUVI,其10.5%的A系列累积永久优先股的交易代码为AUVIP,其财务监督发生了重大变化。该公司宣布,其独立注册会计师事务所Mazars USA LLP正式辞职。此次辞职是在玛扎尔于2024年4月17日发出咨询通知后预料的,该通知表示他们打算辞职,自应用紫外光提交截至2024年3月31日的季度报告起生效,不迟于2024年5月31日。玛泽截至2023年12月31日和2022年12月31日的财政年度的审计报告不包含任何负面意见或免责声明,除了一段关于公司继续经营能力的解释性段落外,没有保留意见或修改。在上述财政...展开全部
2024年5月14日,在纳斯达克股票市场有限责任公司上市的公司,其普通股的交易代码为AUVI,其10.5%的A系列累积永久优先股的交易代码为AUVIP,其财务监督发生了重大变化。该公司宣布,其独立注册会计师事务所Mazars USA LLP正式辞职。此次辞职是在玛扎尔于2024年4月17日发出咨询通知后预料的,该通知表示他们打算辞职,自应用紫外光提交截至2024年3月31日的季度报告起生效,不迟于2024年5月31日。玛泽截至2023年12月31日和2022年12月31日的财政年度的审计报告不包含任何负面意见或免责声明,除了一段关于公司继续经营能力的解释性段落外,没有保留意见或修改。在上述财政年度以及截至辞职之日,公司与玛泽之间在会计原则或惯例、财务报表披露或审计范围或程序方面没有分歧。此外,没有发生S-K法规第304(a)(1)(v)项中定义的应报告事件。应用紫外线已收到玛泽于2024年5月20日发出的信函,信中同意披露中的声明,该披露作为附录16.1附于向美国证券交易委员会提交的报告中。该报告由应用紫外光公司首席财务官迈克·里乔签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息